Analytical Data
-
Gene name
TMEM132A
- Application
-
Alternative Names
HSPA5-binding protein 1 HSPA5BP1, KIAA1583
-
Species
Human
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q24JP5
-
Expression Region
642-742aa
-
Molecular Weight
17.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TMEM132A (Transmembrane Protein 132A) is a gene that encodes a type I transmembrane protein, which is associated with various biological processes and diseases, particularly in the context of human health. Recent studies have highlighted its potential role in modulating immune responses, inflammation, and potentially serving as a biomarker for certain psychiatric disorders, most notably anxiety. Due to its involvement in the regulation of neural activity and emotional behavior, TMEM132A has garnered significant attention in neuroscience and psychiatric research. The use of recombinant TMEM132A proteins has become crucial for dissecting its functional roles and interactions within cellular pathways. Researchers aim to produce these recombinant proteins for structural and functional analysis, enabling the investigation of their mechanisms in stress response and immune system modulation. Understanding the behavior of TMEM132A in vitro can provide insights into its significance in both cellular function and the pathophysiology of anxiety and other related conditions. Such knowledge could inform therapeutic strategies targeting TMEM132A, potentially leading to novel treatments for anxiety disorders and enhancing our understanding of the genetic basis of behavior. Overall, the study of TMEM132A recombinant proteins represents a promising avenue for advancing our comprehension of the underlying mechanisms linking genetics, behavior, and disease.
